1. Home
  2. AM vs ABVX Comparison

AM vs ABVX Comparison

Compare AM & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Antero Midstream Corporation

AM

Antero Midstream Corporation

N/A

Current Price

$22.57

Market Cap

10.2B

Sector

Utilities

ML Signal

N/A

Logo Abivax SA American

ABVX

Abivax SA American

N/A

Current Price

$114.42

Market Cap

10.5B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AM
ABVX
Founded
2013
2013
Country
United States
France
Employees
N/A
67
Industry
Natural Gas Distribution
Sector
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
10.2B
10.5B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
AM
ABVX
Price
$22.57
$114.42
Analyst Decision
Hold
Buy
Analyst Count
3
12
Target Price
$21.33
$128.42
AVG Volume (30 Days)
3.1M
733.0K
Earning Date
05-14-2026
01-01-0001
Dividend Yield
3.92%
N/A
EPS Growth
3.61
N/A
EPS
0.86
N/A
Revenue
$1,188,426,000.00
N/A
Revenue This Year
$3.96
N/A
Revenue Next Year
$6.26
$0.22
P/E Ratio
$26.62
N/A
Revenue Growth
7.43
N/A
52 Week Low
$15.08
$4.77
52 Week High
$23.10
$148.83

Technical Indicators

Market Signals
Indicator
AM
ABVX
Relative Strength Index (RSI) 67.88 45.01
Support Level $17.20 $106.37
Resistance Level N/A $131.27
Average True Range (ATR) 0.49 4.85
MACD -0.04 -1.39
Stochastic Oscillator 76.75 31.26

Price Performance

Historical Comparison
AM
ABVX

About AM Antero Midstream Corporation

Antero Midstream Corp is a midstream company that owns, operates, and develops midstream energy assets that service Antero Resources' production and completion activity in the Appalachian Basin, located in West Virginia and Ohio. The company has two operating segments: the Gathering and Processing segment, which includes a network of gathering pipelines and compressor stations that collect and process production from Antero Resources wells in West Virginia and Ohio, and the Water Handling segment, which includes two independent systems that deliver water from sources including the Ohio River, local reservoirs, and several regional waterways. The company derives a majority of its revenue from the Gathering and Processing segment.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: